1-15493908-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001229.5(CASP9):ā€‹c.1142A>Gā€‹(p.Gln381Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000691 in 1,446,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 6.9e-7 ( 0 hom. )

Consequence

CASP9
NM_001229.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0710
Variant links:
Genes affected
CASP9 (HGNC:1511): (caspase 9) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22390568).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CASP9NM_001229.5 linkuse as main transcriptc.1142A>G p.Gln381Arg missense_variant 8/9 ENST00000333868.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CASP9ENST00000333868.10 linkuse as main transcriptc.1142A>G p.Gln381Arg missense_variant 8/91 NM_001229.5 P1P55211-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.91e-7
AC:
1
AN:
1446660
Hom.:
0
Cov.:
36
AF XY:
0.00
AC XY:
0
AN XY:
718242
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.06e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 24, 2022The c.1142A>G (p.Q381R) alteration is located in exon 8 (coding exon 8) of the CASP9 gene. This alteration results from a A to G substitution at nucleotide position 1142, causing the glutamine (Q) at amino acid position 381 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.099
.;T;.;.
Eigen
Benign
0.020
Eigen_PC
Benign
-0.064
FATHMM_MKL
Benign
0.47
N
LIST_S2
Benign
0.82
T;T;T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.22
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.5
.;M;.;.
MutationTaster
Benign
0.93
N;N;N;N
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.3
N;N;N;N
REVEL
Benign
0.069
Sift
Benign
0.058
T;D;T;T
Sift4G
Benign
0.48
T;T;T;T
Polyphen
0.71
P;P;D;.
Vest4
0.068
MutPred
0.71
Gain of MoRF binding (P = 0.1301);Gain of MoRF binding (P = 0.1301);.;.;
MVP
0.58
MPC
0.38
ClinPred
0.83
D
GERP RS
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.32
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-15820403; API